Targeted metabolomic analysis of early-trimester serum identifies potential mechanisms for late-onset preeclampsia

J Matern Fetal Neonatal Med. 2024 Dec;37(1):2401970. doi: 10.1080/14767058.2024.2401970. Epub 2024 Sep 16.

Abstract

Objective: Preeclampsia (PE) is a pregnancy-specific hypertensive disorder. Late-onset (Lo)-PE can cause serious complications in both the mother and child. This study aimed to explore biomarkers for elucidating the mechanisms underlying Lo-PE, via a metabolomic analysis of first-trimester maternal serum.

Methods: This study was conducted at Fukushima Regional Center as an adjunct to Japan Environment and Children Study and included 12 patients with Lo-PE matched to 12 women with healthy pregnancies. Capillary electrophoresis-mass spectrometry-based quantitative analyses of charged metabolites were performed on first-trimester maternal serum samples.

Results: Overall, 183 charged metabolites were identified. The peak area of glucosamine was significantly higher for the first-trimester sera of patients with Lo-PE than that for controls. Conversely, the peak area of serotonin was significantly decreased in the sera of patients with Lo-PE.

Conclusions: During early pregnancy, glucosamine and serotonin levels in maternal serum may serve as early biomarkers for Lo-PE. As part of preconception care, pre-pregnancy dietary habits and mental health could potentially prevent Lo-PE onset.

Keywords: Late-onset preeclampsia; biomarkers; glucosamine; hypertensive disorders of pregnancy; serotonin.

MeSH terms

  • Adult
  • Biomarkers* / blood
  • Case-Control Studies
  • Female
  • Humans
  • Metabolomics* / methods
  • Pre-Eclampsia* / blood
  • Pre-Eclampsia* / diagnosis
  • Pregnancy
  • Pregnancy Trimester, First* / blood
  • Serotonin / blood

Substances

  • Biomarkers
  • Serotonin